Pro-Dex, Inc. ( PDEX) - Key Metrics
PDEX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q4 | $6.33 | $0.89 | -$0.08 | -$0.11 |
| 2026Q3 | $6.23 | $1.23 | $0.51 | $0.48 |
| 2026Q2 | $5.74 | $0.67 | $1.10 | $1.08 |
| 2026Q1 | $5.68 | $1.43 | $0.71 | $0.68 |
| 2025Q4 | $5.36 | $0.37 | -$0.05 | -$0.08 |
PDEX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q4 | 0% | 16.45 |
| 2026Q3 | 0% | 9.98 |
| 2026Q2 | 0% | 14.36 |
| 2026Q1 | 0% | 5.92 |
| 2025Q4 | 0% | 29.49 |
PDEX
Price: $66.84
52 week price:
Payout Ratio Range:
Earnings Per Share: 4.12 USD
P/E Ratio: 17.82
Exchange: NCM
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: United States
Volume: 13800
Ebitda: 3.9 millionMarket Capitalization: 235.2 million